Vyvyan Campbell, Director at PetLife Pharmaceuticals, Inc. (PTLF), bought 305,000 shares at $4017.00 ($1.2B) on 2018-02-28, disclosed to the SEC on 2018-03-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.